Urological and Genital Diseases: Urological and Genital Diseases
Conditions
Interventions
Informed written consent will be obtained from 100 prospective patients. Pre stent symptom questionnaire will be completed pre-procedure. Each patient will be randomised to receive either the Bard Inl
Sponsors
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Eligibility
Inclusion criteria
Inclusion criteria: Added 28 July 2008: Patients (aged 16 yrs or over) requiring the placement of a ureteric stent for stone disease, including obstructing ureteric stones, large stones prior to lithotripsy or post ureteroscopy plus or minus stone fragmentation.
Exclusion criteria
Exclusion criteria: Added 28 July 2008: Those with pelvi-ureteric junction obstruction, upper tract malignancy, indwelling stent, concurrent urinary tract infection, pregnancy, bilateral instrumentation or aged less than 16 yrs of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Added 28 July 2008: Compare health related QOL (using the USSQ) between the two groups at 2 weeks post insertion of stent | — |
Secondary
| Measure | Time frame |
|---|---|
| Added 28 July 2008: Difference in GP and hospital visits, UTI and antibiotic use between two groups with stent in situ | — |
Countries
United Kingdom
Outcome results
None listed